Radioactive Drug Shortage

The radioactive isotope technetium-99m is used in over 400,000 medical procedures a day, according to the New York Times. This isotope is in high demand, but two of the largest producers of the isotope are shutting down for repairs. This has caused many in the medical community to become worried about a shortage. Substitutes are available, but are generally less effective and more expensive. The isotope is used to test for coronary blockages, breast cancer, kidney functions, and other diagnostic tests. Many times "Tech-99m" is injected into the patient to help locate areas near a cancerous tumor. These tests are often used in conjunction with other diagnostic scanning tests as well. Doctors have already cut back on their use of the Tech-99m isotope, fearing that there will be a shortage in the near future. However, there is research being conducted on viable alternatives for physicians for emergencies such as this. The reactors are being repaired in Canada and are hopeful to reopen at the end of this year.